gastric cancer
ASLAN’s Pan-HER Inhibitor Shows Positive Data In Gastric Cancer PhII Study
ASLAN Pharma announced this week positive data with ASLAN001 in a gastric cancer Phase II study.
GIS, Sengenics Partner On Early Cancer Detection Technology
A*STAR's GIS and Sengenics will partner on cancer biomarker discovery with the aim of identifying and validating auto-antibodies that can be used to detect early-stage cancers.
Researchers Identify Stomach Cancers With Breath Test
A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study.
A*STAR, GE Global Research To Develop Cancer Imaging Technologies
GE Global Research and A*STAR have signed an agreement to develop clinical cancer imaging technologies and diagnostics.
ASLAN Pharma To Develop Bristol-Myers Squibb’s BMS-777607 Compound
ASLAN Pharma and Bristol-Myers Squibb will co-develop an investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.
